Skip to main content
. 2019 Sep 10;10(52):5439–5453. doi: 10.18632/oncotarget.27145

Table 1. Multivariat analysis including established prognostic parameters and the “PSA pattern score” (PSA score).

Tumor subset Scenario p -value
n analyzable preoperative PSA-Level pT Stage cT Stage Gleason grade prostatectomy Gleason grade biopsy pN Stage R Stage PSA score
all cancers 1 6,923 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001
2 10,552 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001
3 10,392 <0.0001 <0.0001 <0.0001 <0.0001
4 8,878 <0.0001 <0.0001 <0.0001 <0.0001
ERG-negative cancers 1 2,723 0.0002 <0.0001 <0.0001 0.0008 0.0848 <0.0001
2 4,245 <0.0001 <0.0001 <0.0001 0.0033 <0.0001
3 4,206 <0.0001 <0.0001 <0.0001 <0.0001
4 4,138 <0.0001 <0.0001 <0.0001 <0.0001
ERG-positive cancers 1 2,134 0.0225 <0.0001 <0.0001 0.2417 0.0002 0.0226
2 3,339 0.0002 <0.0001 <0.0001 <0.0001 0.0295
3 3,282 <0.0001 <0.0001 <0.0001 0.0042
4 3,229 <0.0001 <0.0001 <0.0001 <0.0001

For definition of the scenarios, see Statistics section.